Vertigo Treatment Receives FDA Breakthrough Device Designation, featuring Otolith Labs
Otolith Labs, launched at the Halcyon Incubator, has received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its medical device that is designed to be prescribed by physicians for the treatment of vertigo. Read More →